title: [Improvements in palliative treatment of colorectal carcinoma].
authors.affiliation: Medizinischen Klinik, Friedrich-Alexander-Universität Erlangen-Nürnberg. axel.wein@med1.med.uni-erlangen.de
authors.forename: A
authors.initials: A
authors.lastname: Wein
authors.forename: C
authors.initials: C
authors.lastname: Riedel
authors.forename: B
authors.initials: B
authors.lastname: Hanke
authors.forename: S
authors.initials: S
authors.lastname: Lampert
authors.forename: W
authors.initials: W
authors.lastname: Brückl
authors.forename: B
authors.initials: B
authors.lastname: Reingruber
authors.forename: W
authors.initials: W
authors.lastname: Hohenberger
authors.forename: E G
authors.initials: EG
authors.lastname: Hahn
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000401:mortality; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage / Q000009:adverse effects; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary; D010166:Palliative Care; D015996:Survival Rate
chemical_list: D000970:Antineoplastic Agents; D002955:Leucovorin; D005472:Fluorouracil